Enzyme immunoassay for estimation of S100 protein in blood serum as a method of early diagnosis and efficiency assessment of multiple sclerosis pathogenetic therapy - Статья
Acquaintance with the main causes of the incidence of multiple sclerosis, consideration of diagnostic methods. Multiple sclerosis as a chronic progressive disease by the central nervous system, which primarily affects people of young and middle age.
Аннотация к работе
Enzyme immunoassay for estimation of S100 protein in blood serum as a method of early diagnosis and efficiency assessment of multiple sclerosis pathogenetic therapy The incidence of multiple sclerosis (MS), a disease that primarily affects people between the ages of 18 and 55, has been steadily increasing all over the world. MS is associated with a progressive increase of neurological deficit and is one of the main causes of disability. It sometimes takes a few months or even years to diagnose MS as the demyelination process has to spread in space and time (the 2005-2010 McDonald Criteria). Therefore, it is of importance to make the diagnosis at the early symptoms of the disease, because the earlier pathogenetic therapy results in less evident disability processes in MS patients. Introduction Multiple sclerosis (MS) is a chronic progressive disease of the CNS that primarily affects young and middle-aged people [5]. The incidence of MS has been steadily increasing over the past decade and becoming an important